Ilkka T Harvima

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Cell Cycle Arrest

Induced Apoptosis

Top Venues

Clinical and experimental immunology

Experimental dermatology

Clinical case reports

Analytical cellular pathology (Amsterdam)

This page only lists publications with an associated author ORCID identifier.

Publications

Dina Rahkola, Rauno J Harvima, Ilkka T Harvima
Increased expression of complement C3c, iC3b, and cells containing CD11b or CD14 in experimentally induced psoriatic lesion. Clinical and experimental immunology 216 (3) (2024)
Rauno J Harvima, Tarja Heiskanen-Kosma, Miika Arvonen, Ilkka T Harvima
Diagnostic challenge of an untypical cutaneous drug reaction from modafinil. Clinical case reports 12 (9) (2024)
Dina Rahkola, Rauno J Harvima, Ilkka T Harvima
Increased expression of complement C3c, iC3b, and cells containing CD11b or CD14 in experimentally induced psoriatic lesion. Clinical and experimental immunology 216 (3) (2024)
Dina Rahkola, Rauno J Harvima, Ilkka T Harvima
Increased expression of complement C3c, iC3b, and cells containing CD11b or CD14 in experimentally induced psoriatic lesion. Clinical and experimental immunology 216 (3) (2024)
Dina Rahkola, Rauno J Harvima, Ilkka T Harvima
Increased expression of complement C3c, iC3b, and cells containing CD11b or CD14 in experimentally induced psoriatic lesion. Clinical and experimental immunology 216 (3) (2024)
Salla Haimakainen, Ilkka T Harvima
Corticotropin-releasing hormone receptor-1 is increased in mast cells in psoriasis and actinic keratosis, but not markedly in keratinocyte skin carcinomas. Experimental dermatology (2023)
Ilkka T Harvima, Rauno J Harvima
Survival from cutaneous malignant melanoma is improving, but is it because of a trend in decreasing melanoma thickness or the advent of new 'revolutionary' therapeutics? The British journal of dermatology 187 (1) (2022)
Dina Rahkola, Tiina Lipitsä, Hanna Siiskonen, Anita Naukkarinen, Ilkka T Harvima
Sequential Increase in Complement Factor I, iC3b, and Cells Expressing CD11b or CD14 in Cutaneous Vasculitis. Analytical cellular pathology (Amsterdam) 2022 (2022)